Last reviewed · How we verify
NVN1000 4% Gel
At a glance
| Generic name | NVN1000 4% Gel |
|---|---|
| Also known as | NVN1000, SB204 |
| Sponsor | Novan, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne (PHASE3)
- P3 Study in Acne Comparing Once Daily SB204 and Vehicle (PHASE3)
- P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris (PHASE2)
- P3 Long Term Safety Study of Once Daily SB204 in Acne (PHASE3)
- A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum (PHASE2)
- Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers (PHASE1)
- SB208 for the Treatment of Tinea Pedis (PHASE2)
- A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |